We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current INNMF market cap is 9.76M. The company's latest EPS is NZD -0.0232 and P/E is -3.88.
Year End 31 March 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
NZD ($) | NZD ($) | NZD ($) | NZD ($) | NZD ($) | |
Total Revenue | 34k | 1.59M | 1.98M | 1.19M | 4.45M |
Operating Income | -2.23M | -2.28M | -3.64M | -6.29M | -4.57M |
Net Income | -2.22M | -2.28M | -3.64M | -6.24M | -4.5M |
Year End 31 March 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
NZD ($) | NZD ($) | NZD ($) | NZD ($) | NZD ($) | |
Total Assets | 9.12M | 10.88M | 24.48M | 18.68M | 14.85M |
Total Liabilities | 511k | 539k | 2.64M | 2.85M | 3.43M |
Total Equity | 8.61M | 10.34M | 21.85M | 15.84M | 11.42M |
Year End 31 March 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
NZD ($) | NZD ($) | NZD ($) | NZD ($) | NZD ($) | |
Operating | -2.09M | -2.92M | -4.4M | -5.29M | -5.13M |
Investing | N/A | -5k | -26k | -58k | -2k |
Financing | 1.96M | 3.66M | 17.19M | -84k | -773k |
Market Cap | 9.76M |
Price to Earnings Ratio | -3.88 |
Price to Sales Ratio | 3.91 |
Price to Cash Ratio | 5.17 |
Price to Book Ratio | 1.53 |
Dividend Yield | - |
Shares Outstanding | 194.01M |
Average Volume (1 week) | 169.9k |
Average Volume (1 Month) | 67.66k |
52 Week Change | -5.88% |
52 Week High | 0.155 |
52 Week Low | 0.0313 |
Spread (Intraday) | 6.42 (99.53%) |
Company Name | Amplia Therapeutics Ltd (PK) |
Address |
level 17 melbourne, victoria 3000 |
Website | https://www.ampliatx.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions